U3O8 Corp. , announces a positive start to studies designed to improve the bottom line of the Company's Berlin Project. An initial study of the feasibility of membrane separation technology to enhance the economics of the Project indicates that membrane separation is likely to simplify the extraction of metals and phosphate from this multi-commodity deposit. Dr. Richard Spencer, U3O8 Corp.'s President and CEO commented [...]
U3O8 Corp. announces that International Consolidated Uranium Inc. has chosen to exercise its option to purchase the Laguna Salada Project in Argentina from U3O8 Corp. The terms of the option agreement were outlined in U3O8 Corp.'s press release dated December 14, 2020. The cash component of the purchase will be used to advance U3O8 Corp.'s Berlin Deposit that contains uranium, a suite of battery commodities and rare earth [...]
U3O8 Corp. announces that it has commenced staged test work to determine the efficiency of membranes to recover battery commodities from its Berlin Deposit in Colombia. The objective of the test work is to determine the cost-effectiveness of membrane separation to concentrate battery commodities such as nickel, vanadium and phosphate, among others, as well as uranium, after they have been leached from the mineralized [...]
U3O8 Corp. , is pleased to announce that further to its news releases dated January 28, 2021, February 12, 2021 and February 16, 2021, it has completed its previously announced non-brokered private placement. The Company issued 6,666,668 units at a price of $0.15 per Unit, for total gross proceeds of $1,000,000 . Each Unit consists of one common share in the capital stock of U3O8 and one common share purchase warrant [...]
U3O8 Corp. , wishes to correct the press release issued on February 12, 2021. The Company announces that it is increasing the size of the non-brokered private placement of units of the Company originally announced on January 27, 2021 from $500,000, to gross proceeds of up to $1,000,000 . Pricing The Company intends to sell up to 6,666,666 Units at a price of C$0.15 per Unit. Each Unit shall consist of a common share of [...]
U3O8 Corp. , announces that it is increasing the size of the non-brokered private placement of units of the Company announced on January 27, 2021 from $500,000, to gross proceeds of up to $1,000,000 . Pricing The Company intends to sell up to 6,666,666 Units at a price of C$0.15 per Unit. Each Unit shall consist of a common share of the Company and a common share purchase warrant . Each Warrant entitles the holder to [...]
U3O8 Corp. announces that its board of directors has approved undertaking a non-brokered private placement to raise gross proceeds of C$500,000 . Pricing The Company intends to sell 3,333,333 units at a price of C$0.15. Each Unit consists of a common share of the Company and a common share purchase warrant . Each Warrant entitles the holder to purchase one Common Share at an exercise price of C$0.20 for a period of 12 [...]
U3O8 Corp. announces that it has entered into an agreement whereby International Consolidated Uranium Inc. has the option to acquire the Laguna Salada uranium-vanadium deposit in Argentina. U3O8 Corp.'s President & CEO, Dr. Richard Spencer commented, "The Board of U3O8 Corp. has mapped out an alternative course for the Company that involves a change in focus that will unfold in due course. The first step in the [...]
U3O8 Corp. , announces that it has issued an aggregate total of 860,000 stock options to board members, management and consultants. The stock options have a five-year term and an exercise price of $0.12, corresponding to the closing price of the Company's stock on the NEX platform of the TSX Venture Exchange on August 21, 2020. These options comply with the Company's standard option practice with one quarter of the [...]
U3O8 Corp. , is pleased to announce that its shareholders have approved all of the resolutions put before them at the Company's Annual General Meeting held in Toronto on Friday, August 7, 2020. Shareholders approved the financial statements for the year-ended December 31, 2019 and the report of the auditors thereon, the appointment of auditors, election of directors and the Company's equity-based incentive plan for the [...]
U3O8 Corp. , reports that, further to the press release dated March 30, 2020, announcing that the Company would not be proceeding with the reverse takeover described in its March 2, 2020 press release, the Company’s submission to TSX Venture Exchange for the lifting of the halt on trading of the Company’s shares, has been accepted. Subject to final regulatory approval, trading of the Company’s common shares will resume on [...]
U3O8 Corp. announces that, further to the press release dated March 2, 2020, the letter of intent between the Company and Diagnostic Lab Corporation, Inc. to negotiate and complete a proposed reactivation transaction, has been terminated in accordance with the provisions of the LOI, and the transaction contemplated therein will not proceed. The Company will continue to evaluate other acquisition opportunities with a view [...]
+450,00 %
-27,27 %
